BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 28364304)

  • 1. Inter-Subject Variability in OCT1 Activity in 27 Batches of Cryopreserved Human Hepatocytes and Association with OCT1 mRNA Expression and Genotype.
    Fattah S; Shinde AB; Matic M; Baes M; van Schaik RHN; Allegaert K; Parmentier C; Richert L; Augustijns P; Annaert P
    Pharm Res; 2017 Jun; 34(6):1309-1319. PubMed ID: 28364304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of OATP-, NTCP- and OCT-mediated substrate uptake activities in individual and pooled batches of cryopreserved human hepatocytes.
    De Bruyn T; Ye ZW; Peeters A; Sahi J; Baes M; Augustijns PF; Annaert PP
    Eur J Pharm Sci; 2011 Jul; 43(4):297-307. PubMed ID: 21605667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) is affected by genetic factors and cholestasis in human liver.
    Nies AT; Koepsell H; Winter S; Burk O; Klein K; Kerb R; Zanger UM; Keppler D; Schwab M; Schaeffeler E
    Hepatology; 2009 Oct; 50(4):1227-40. PubMed ID: 19591196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vectorial transport of the plant alkaloid berberine by double-transfected cells expressing the human organic cation transporter 1 (OCT1, SLC22A1) and the efflux pump MDR1 P-glycoprotein (ABCB1).
    Nies AT; Herrmann E; Brom M; Keppler D
    Naunyn Schmiedebergs Arch Pharmacol; 2008 Feb; 376(6):449-61. PubMed ID: 18157518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) in human hepatocellular carcinoma and their prognostic significance.
    Heise M; Lautem A; Knapstein J; Schattenberg JM; Hoppe-Lotichius M; Foltys D; Weiler N; Zimmermann A; Schad A; Gründemann D; Otto G; Galle PR; Schuchmann M; Zimmermann T
    BMC Cancer; 2012 Mar; 12():109. PubMed ID: 22439694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of human organic cation transporter 1 (OCT1/SLC22A1)- and OCT2 (SLC22A2)-mediated transport of 1-(2-methoxyethyl)-2-methyl-4,9-dioxo-3-(pyrazin-2-ylmethyl)- 4,9-dihydro-1H-naphtho[2,3-d]imidazolium bromide (YM155 monobromide), a novel small molecule survivin suppressant.
    Minematsu T; Iwai M; Umehara K; Usui T; Kamimura H
    Drug Metab Dispos; 2010 Jan; 38(1):1-4. PubMed ID: 19833842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of organic cation transporter 1 (SLC22A1) is associated with tumor progression and reduced patient survival in human cholangiocellular carcinoma.
    Lautem A; Heise M; Gräsel A; Hoppe-Lotichius M; Weiler N; Foltys D; Knapstein J; Schattenberg JM; Schad A; Zimmermann A; Otto G; Lang H; Galle PR; Schuchmann M; Zimmermann T
    Int J Oncol; 2013 Apr; 42(4):1297-304. PubMed ID: 23440379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional characterization of the organic cation transporters (OCTs) in human airway pulmonary epithelial cells.
    Ingoglia F; Visigalli R; Rotoli BM; Barilli A; Riccardi B; Puccini P; Dall'Asta V
    Biochim Biophys Acta; 2015 Jul; 1848(7):1563-72. PubMed ID: 25883089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphine is a substrate of the organic cation transporter OCT1 and polymorphisms in OCT1 gene affect morphine pharmacokinetics after codeine administration.
    Tzvetkov MV; dos Santos Pereira JN; Meineke I; Saadatmand AR; Stingl JC; Brockmöller J
    Biochem Pharmacol; 2013 Sep; 86(5):666-78. PubMed ID: 23835420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transport of the fluorescent organic cation 4-(4-(dimethylamino)styryl)-N-methylpyridinium iodide (ASP+) in human respiratory epithelial cells.
    Salomon JJ; Endter S; Tachon G; Falson F; Buckley ST; Ehrhardt C
    Eur J Pharm Biopharm; 2012 Jun; 81(2):351-9. PubMed ID: 22426135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Organic Cation Transporters (OCT-SLC22A) on Differential Diagnosis of Intrahepatic Lesions.
    Visentin M; van Rosmalen BV; Hiller C; Bieze M; Hofstetter L; Verheij J; Kullak-Ublick GA; Koepsell H; Phoa SS; Tamai I; Bennink RJ; van Gulik TM; Stieger B
    Drug Metab Dispos; 2017 Feb; 45(2):166-173. PubMed ID: 27903597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-affinity uptake of the fluorescent organic cation 4-(4-(dimethylamino)styryl)-N-methylpyridinium iodide (4-Di-1-ASP) in BeWo cells.
    Rytting E; Bryan J; Southard M; Audus KL
    Biochem Pharmacol; 2007 Mar; 73(6):891-900. PubMed ID: 17174940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucocorticoid receptor regulates organic cation transporter 1 (OCT1, SLC22A1) expression via HNF4α upregulation in primary human hepatocytes.
    Rulcova A; Krausova L; Smutny T; Vrzal R; Dvorak Z; Jover R; Pavek P
    Pharmacol Rep; 2013; 65(5):1322-35. PubMed ID: 24399729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deficiency in the organic cation transporters 1 and 2 (Oct1/Oct2 [Slc22a1/Slc22a2]) in mice abolishes renal secretion of organic cations.
    Jonker JW; Wagenaar E; Van Eijl S; Schinkel AH
    Mol Cell Biol; 2003 Nov; 23(21):7902-8. PubMed ID: 14560032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of cryopreservation on the activity of OATP1B1/3 and OCT1 in isolated human hepatocytes.
    Badolo L; Trancart MM; Gustavsson L; Chesné C
    Chem Biol Interact; 2011 Apr; 190(2-3):165-70. PubMed ID: 21356203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High affinity of 4-(4-(dimethylamino)styryl)-N-methylpyridinium transport for assessing organic cation drugs in hepatocellular carcinoma cells.
    Jinakote M; Ontawong A; Soodvilai S; Pimta J; Pasachan T; Chatsudthipong V; Srimaroeng C
    Fundam Clin Pharmacol; 2020 Jun; 34(3):365-379. PubMed ID: 31883148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of air-interfaced Calu-3 cell layers for investigation of inhaled drug interactions with organic cation transporters in vitro.
    Mukherjee M; Pritchard DI; Bosquillon C
    Int J Pharm; 2012 Apr; 426(1-2):7-14. PubMed ID: 22265910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of organic cation transporter 1 (OCT1): unique patterns of indirect regulation by nuclear receptors and hepatospecific gene regulation.
    Hyrsova L; Smutny T; Trejtnar F; Pavek P
    Drug Metab Rev; 2016 May; 48(2):139-58. PubMed ID: 27278216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MPP
    Mocking TAM; Sijben HJ; Vermeulen YW; IJzerman AP; Heitman LH
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genotype-dependent effects of inhibitors of the organic cation transporter, OCT1: predictions of metformin interactions.
    Ahlin G; Chen L; Lazorova L; Chen Y; Ianculescu AG; Davis RL; Giacomini KM; Artursson P
    Pharmacogenomics J; 2011 Dec; 11(6):400-11. PubMed ID: 20567254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.